AWM Investment Company’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

AWM Investment Company’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-150,000	Closed	-$3.29M	–	101
2017 Q4	$3.29M	Buy	150,000 +50,000	+50%	+$1.61M	0.64%	50
2017 Q3	$4.09M	Hold	100,000	–	–	0.71%	41
2017 Q2	$3.01M	Buy	100,000 +20,000	+25%	+$624K	0.53%	50
2017 Q1	$2.89M	Hold	80,000	–	–	0.54%	50
2016 Q4	$4.01M	Hold	80,000	–	–	0.79%	42
2016 Q3	$4.2M	Sell	80,000 -10,000	-11%	-$478K	0.77%	41
2016 Q2	$3.72M	Sell	90,000 -28,199	-24%	-$1.23M	0.8%	41
2016 Q1	$4.8M	Hold	118,199	–	–	1.01%	37
2015 Q4	$4.91M	Hold	118,199	–	–	0.96%	33
2015 Q3	$1.82M	Hold	118,199	–	–	0.35%	67
2015 Q2	$2.94M	Sell	118,199 -181,801	-61%	-$4.05M	0.42%	73
2015 Q1	$6.86M	Hold	300,000	–	–	0.95%	40
2014 Q4	$8.1M	Buy	+300,000	New	+$5.16M	1.1%	31

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

AWM Investment Company's FPRX Position: Q1 2018 in Review

AWM Investment Company sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2018, closing a stake of 150,000 shares — an estimated $3.29M sold.

AWM Investment Company first reported a position in FPRX in Q4 2014 and held it in 13 quarters. The position peaked at $8.1M in Q4 2014. 128 funds tracked by Wall St. Rank hold FPRX as of Q1 2018.

AWM Investment Company reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
AWM Investment Company sold 150,000 Five Prime Therapeutics, Inc. shares in Q1 2018, an estimated $3.29M.
AWM Investment Company first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
AWM Investment Company's Five Prime Therapeutics, Inc. position peaked at $8.1M in Q4 2014.
128 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2018.

Based on AWM Investment Company's 13F filing for Q1 2018, filed 10 May 2018.